EGFR mutation testing and treatment with tyrosin-kinase inhibitors in patients with metastatic non-small cell lung cancer treated by office based medical oncologists in Germany – data from the clinical registry on lung cancer (TLK).

Bertram, M., Petersen, V., Heßling, J., Tessen, H.W., Münz, M., Jänicke, M., Spring, L., Marschner, N., 2015.

Oncol Res Treat 38 (suppl 5)(V886), 269. doi:10.1159/000439070

Studie: TLK; Indikation: Bronchialkarzinom; Jahr: 2015; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0